Introducing Oral Tirzepatide: A Convenient Alternative to Weekly Injections Were excited to announce a new treatment option for our patients: Oral Tirzepatide
In the recently published SURMOUNT-5 trial, which evaluated weight reduction over 72 weeks with the maximum tolerated dose of tirzepatide (10 or 15 mg) vs semaglutide (1.7 or 2.4 mg) in adults with obesity without type 2 diabetes, tirzepatide showed superior efficacy
Great skin isnt achieved overnight its restored one cell at a time. Book your personalized consultation today to start your skin-brightening journey safely and confidently.
UK product information (SmPCs) for both Wegovy and Saxenda advise monitoring for mood changes and depression, and to discontinue treatment and seek medical advice promptly if suicidal thoughts occur
To view a copy of this licence, visit About this article Cite this article Singh, R., Shah, A., Jain, N